Company: ZVRA
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001437749-25-016523
Chunk: 66

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 66
---
Item 1. 
      unaudited condensed CONSOLIDATED Financial Statements 

ZEVRA THERAPEUTICS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and par value amounts)

      March 31,    December 31,  
   2025    2024  
 Assets         
 Current assets:         
 Cash and cash equivalents  $37,340  $33,785 
 Securities at fair value, current   25,291   35,711 
 Accounts and other receivables   12,617   10,509 
 Prepaid expenses and other current assets   3,766   4,052 
 Inventories, current   2,559   1,970 
 Total current assets   81,573   86,027 
 Securities at fair value, noncurrent   6,091   6,010 
 Inventories, noncurrent   10,615   10,999 
 Property and equipment, net   422   356 
 Operating lease right-of-use assets   1,636   657 
 Goodwill   4,701   4,701 
 Intangible assets, net   67,377   68,993 
 Other long-term assets   293   384 
 Total assets  $172,708  $178,127 
         
 Liabilities and stockholders' equity         
 Current liabilities:         
 Accounts payable and accrued expenses  $17,819  $25,456 
 Current portion of operating lease liabilities   589   420 
 Current portion of discount and rebate liabilities   5,167   4,989 
 Other current liabilities   3,401   3,200 
 Total current liabilities   26,976   34,065 
 Long-term debt   60,090   59,504 
 Warrant liability   13,030   17,804 
 Income tax payable   16,166   14,431 
 Operating lease liabilities, less current portion   1,158   372 
 Discount and rebate liabilities, less current portion   9,389   7,655 
 Other long-term liabilities   4,876   4,630 
 Total liabilities   131,685   138,461 
         
 Commitments and contingencies (Note M)